by Corina Milic | Dec 16, 2015
In 2014 CHAI led a study, in collaboration with the Kano State Ministry of Health, to assess whether integrating seasonal malaria chemoprevention (SMC) with Plumpy’doz™, a lipid-based nutritional supplement (LNS), has an impact on nutrition or malaria outcomes. This...
by Corina Milic | Nov 3, 2015
Early testing of HIV-exposed infants and the initiation of antiretroviral therapy for HIV-positive infants is critical to improving infant survival. Learn about evidence from a Demand-Driven Evaluations for Decisions (3DE) Evaluation in Southern Province, Zambia that...
by Corina Milic | Sep 29, 2015
Malaria rapid diagnostic tests (RDTs) are an effective tool for confirming true malaria cases in resource-limited settings, yet are often unavailable in the private sector where many seek treatment. CHAI worked with global manufacturers and importers in...
by Corina Milic | Sep 2, 2015
In July 2014, CHAI and partners began work to implement a comprehensive Maternal and Newborn Health (MNH) program aimed at improving maternal and newborn health outcomes in the States of Kano, Katsina and Kaduna, northern Nigeria. A component of the program aims to...
by Corina Milic | Aug 11, 2015
Treating severe malaria with injectable artesunate instead of quinine can substantially reduce mortality. To increase uptake and improve health outcomes, CHAI supported ministries of health in six high-burden countries to overcome barriers to adoption. Learn more...
by Corina Milic | Aug 11, 2015
Access to better tolerated, more convenient regimens for HIV treatment promotes adherence and leads to better patient outcomes. CHAI is working to ensure affordable pricing and to address demand-side barriers to access. Increased uptake of optimal second-line regimens...
